MARKET

HSKA

HSKA

Heska
NASDAQ

Real-time Quotes | Nasdaq Last Sale

97.87
+3.36
+3.56%
After Hours: 97.87 0 0.00% 16:05 07/01 EDT
OPEN
94.66
PREV CLOSE
94.51
HIGH
98.47
LOW
93.69
VOLUME
54.60K
TURNOVER
0
52 WEEK HIGH
275.94
52 WEEK LOW
79.96
MARKET CAP
1.06B
P/E (TTM)
-77.1724
1D
5D
1M
3M
1Y
5Y
Is Heska (NASDAQ:HSKA) Using Debt Sensibly?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Simply Wall St. · 06/22 15:03
Heska to Present at the Upcoming Stifel 2022 Jaws and Paws Conference
Heska Corporation (NASDAQ: HSKA; "Heska" or the "Company"), a leading global provider of advanced veterinary diagnostic and specialty solutions, announced that Kevin Wilson, Heska's President & Chief Executive Officer, will present at the Stifel 2022 Jaws ...
PR Newswire · 05/25 12:00
Piper Sandler Adjusts Heska's Price Target to $180 From $190, Reiterates Overweight Rating
MT Newswires · 05/16 07:10
Analyst Ratings for Heska
Over the past 3 months, 4 analysts have published their opinion on Heska (NASDAQ:HSKA) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upc...
Benzinga · 05/10 13:16
--Morgan Stanley Adjusts Heska's Price Target to $149 from $161, Keeps Equalweight Rating
MT Newswires · 05/10 12:58
Update: Heska's Shares Drop After Q1 Non-GAAP Net Income Declines
MT Newswires · 05/09 14:17
Heska (HSKA) Misses Q1 Earnings and Revenue Estimates
Heska (HSKA) delivered earnings and revenue surprises of -34.15% and 3.44%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 05/09 13:35
Heska Q1 EPS $0.27 Down From $0.59 YoY, Sales $64.80M Miss $65.92M Estimate
Heska (NASDAQ:HSKA) reported quarterly earnings of $0.27 per share. This is a 54.24 percent decrease over earnings of $0.59 per share from the same period last year. The company reported quarterly sales of $64.80
Benzinga · 05/09 12:09
More
No Data
Learn about the latest financial forecast of HSKA. Analyze the recent business situations of Heska through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 6 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

0.00%Strong Buy
50.00%Buy
50.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average HSKA stock price target is 145.25 with a high estimate of 180.00 and a low estimate of 97.00.
High180.00
Average145.25
Low97.00
Current 97.87
EPS
Actual
Estimate
-0.77-0.58-0.38-0.18
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Institutional Holdings
Institutions: 216
Institutional Holdings: 12.30M
% Owned: 113.98%
Shares Outstanding: 10.79M
TypeInstitutionsShares
Increased
69
551.82K
New
14
101.52K
Decreased
64
344.66K
Sold Out
30
226.78K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+2.13%
Healthcare Equipment & Supplies
+1.92%
Key Executives
Non-Executive Chairman/Independent Director
Scott Humphrey
President/Chief Executive Officer/Director
Kevin Wilson
Chief Financial Officer/Executive Vice President
Catherine Grassman
Chief Operating Officer/Executive Vice President
Nancy Wisnewski
Executive Vice President/Chief Administrative Officer/General Counsel/Secretary
Christopher Sveen
Executive Vice President
Eleanor Baker
Executive Vice President
Steven Eyl
Director
David Sveen
Independent Director
Robert Antin
Independent Director
Stephen Davis
Independent Director
Mark Furlong
Independent Director
Joachim Hasenmaier
Independent Director
Sharon Maples
No Data
No Data
About HSKA
Heska Corporation manufactures, develops and sells advanced veterinary diagnostic and specialty healthcare products. The Company's segments include North America segment includes the contract manufacturing of vaccines and pharmaceutical products, and International consists of geographies outside of North America, primarily its operations in Australia, France, Germany, Italy, Malaysia, Spain and Switzerland. The Company's veterinary instruments include Element RC, Element RCX and Element RC3X. The Company is offerings include Point of Care diagnostic laboratory instruments and consumables; Point of Care digital imaging diagnostic products; reference laboratory testing; digital cytology services; vaccines; local and cloud-based data services; allergy testing and immunotherapy; single-use offerings such as in-clinic diagnostic tests and heartworm preventive products, and practice information management software and related software.

Webull offers kinds of Heska Corp stock information, including NASDAQ:HSKA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HSKA stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading HSKA stock methods without spending real money on the virtual paper trading platform.